nuaxia | Blog

nuaxia

23 hours ago3 min read

Breaking the BTK Code: Roche Goes All-In on Degrader Strategy with $2.3B Nurix Deal

nuaxia

3 days ago3 min read

Philips Takes Ultrasound Into the AI Workflow Era with FDA Clearance for Elevate Plus

nuaxia

4 days ago4 min read

ResMed Acquires Noctrix Health for $340m to Expand Beyond Sleep Apnoea

dan73778

5 days ago3 min read

Alnylam and Inceptive Launch $2B AI Partnership to Accelerate RNAi Drug Discovery

nuaxia

6 days ago3 min read

Lilly and Ascidian Enter $1.9bn Partnership to Advance RNA Exon Editing in Monogenic Kidney Disease

nuaxia

7 days ago4 min read

A Standing Ovation for a New Chapter in Pancreatic Cancer

nuaxia

Jun 22 min read

FDA Approves AstraZeneca’s Imfinzi Plus BCG for High-Risk Bladder Cancer

dan73778

May 302 min read

Innovent Biologics and Pfizer Form $10bn+ Oncology Alliance Across 12 Cancer Programs

nuaxia

May 303 min read

Eli Lilly Builds Infectious Disease Platform with Three-Acquisition Strategy

nuaxia

May 293 min read

Jardine Matheson Acquires I-MED Radiology Network in $2.4bn Healthcare Imaging Deal

nuaxia

May 273 min read

Parabilis Medicines Files IPO to Fund Phase III Expansion of Helicon-Based Oncology Pipeline

nuaxia

May 262 min read

GHO Capital and CBC Group Merge to Create $21bn Global Healthcare Investment Platform

nuaxia

May 223 min read

Decart Raises $300m to Scale Real-Time AI Infrastructure and World Models

nuaxia

May 202 min read

Regeneron Expands Intracellular Drug Platform Strategy with $2.32bn Parabilis Collaboration

nuaxia

May 193 min read

Boston Scientific Invests $1.5bn for Strategic Equity Stake in MiRus TAVR Platform

nuaxia

May 182 min read

FDA Approves Roche’s Tecentriq in First ctDNA-Guided Cancer Therapy

nuaxia

May 162 min read

FDA Leadership Turmoil Deepens Following Marty Makary’s Resignation

nuaxia

May 152 min read

Big Pharma Isn’t Just Buying From China Anymore — It’s Building With It

nuaxia

May 71 min read

Bayer Expands Ophthalmology Pipeline with $2.45B Perfuse Therapeutics Acquisition

nuaxia

May 61 min read

Breaking the BTK Code: Roche Goes All-In on Degrader Strategy with $2.3B Nurix Deal

Philips Takes Ultrasound Into the AI Workflow Era with FDA Clearance for Elevate Plus

ResMed Acquires Noctrix Health for $340m to Expand Beyond Sleep Apnoea

Alnylam and Inceptive Launch $2B AI Partnership to Accelerate RNAi Drug Discovery

Lilly and Ascidian Enter $1.9bn Partnership to Advance RNA Exon Editing in Monogenic Kidney Disease

A Standing Ovation for a New Chapter in Pancreatic Cancer

FDA Approves AstraZeneca’s Imfinzi Plus BCG for High-Risk Bladder Cancer

Innovent Biologics and Pfizer Form $10bn+ Oncology Alliance Across 12 Cancer Programs

Eli Lilly Builds Infectious Disease Platform with Three-Acquisition Strategy

Jardine Matheson Acquires I-MED Radiology Network in $2.4bn Healthcare Imaging Deal

Parabilis Medicines Files IPO to Fund Phase III Expansion of Helicon-Based Oncology Pipeline

GHO Capital and CBC Group Merge to Create $21bn Global Healthcare Investment Platform

Decart Raises $300m to Scale Real-Time AI Infrastructure and World Models

Regeneron Expands Intracellular Drug Platform Strategy with $2.32bn Parabilis Collaboration

Boston Scientific Invests $1.5bn for Strategic Equity Stake in MiRus TAVR Platform

FDA Approves Roche’s Tecentriq in First ctDNA-Guided Cancer Therapy

FDA Leadership Turmoil Deepens Following Marty Makary’s Resignation

Big Pharma Isn’t Just Buying From China Anymore — It’s Building With It

Bayer Expands Ophthalmology Pipeline with $2.45B Perfuse Therapeutics Acquisition

Novo Nordisk Launches Oral Ozempic in US Diabetes Market